InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Taubert Jennifer L, Directrice Exécutive. Officer active across 1 company, notably Johnson & Johnson. Aggregated, 3 disclosures have been logged. Activity tracked since 14 February 2022. The latest transaction was disclosed on 15 February 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations3 total
18,064 shares0Common StockSEC:0001225208-22-002377:0
18,064 shares0Common StockSEC:0001225208-22-002377
3,297 shares0Common StockSEC:0001225208-22-002211:0
3 of 3 declarations
About Taubert Jennifer L
Jennifer L. Taubert serves as Executive Vice President and Worldwide Chair of Pharmaceuticals at Johnson & Johnson. She oversees global operations and strategies for pharmaceutical product development. Jennifer plays a key role in innovation and continuous improvement of the company's products.
